Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 versus Placebo in Participants with Major Depressive Disorder

Project: Research

Project Details

StatusActive
Effective start/end date10/29/24 → 03/31/27

Funding

  • Neumora Therapeutics Incorporated: $44,225.50